|
||||||
Executive Summary Summary Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI's major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in-vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company Universal Biosensors Inc The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research & Development strategies Develop market-entry and market expansion strategies Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Universal Biosensors Inc Company Overview 4 Universal Biosensors Inc Company Snapshot 4 Universal Biosensors Inc Pipeline Products and Ongoing Clinical Trials Overview 4 Universal Biosensors Inc-Pipeline Analysis Overview 7 Business Description 7 Universal Biosensors Inc-Key Facts 7 Universal Biosensors Inc-Major Products and Services 8 Universal Biosensors Inc Pipeline Products by Development Stage 9 Universal Biosensors Inc Pipeline Products Overview 11 C-Reactive Protein Test 11 C-Reactive Protein Test Product Overview 11 Diagnostic Assay-Coagulation 12 Diagnostic Assay-Coagulation Product Overview 12 DNA/RNA Blood Glucose Test 13 DNA/RNA Blood Glucose Test Product Overview 13 Handheld POC Coagulation Testing System-Ambulatory Care 14 Handheld POC Coagulation Testing System-Ambulatory Care Product Overview 14 Immunoassay Test-D-Dimer 15 Immunoassay Test-D-Dimer Product Overview 15 PT-INR Testing System-Decentralised And Home Use 16 PT-INR Testing System-Decentralised And Home Use Product Overview 16 Universal Biosensors Inc-Key Competitors 17 Universal Biosensors Inc-Key Employees 18 Universal Biosensors Inc-Key Employee Biographies 19 Universal Biosensors Inc-Locations And Subsidiaries 20 Head Office 20 Other Locations & Subsidiaries 20 Recent Developments 21 Universal Biosensors Inc, Recent Developments 21 May 08, 2017: Commencement of Xprecia Stride Coagulation Analyser sales activities in the US market 21 Oct 04, 2016: Siemens Receives FDA Clearance of the Xprecia Stride Coagulation Analyzer 21 Jun 30, 2016: UBI appoints Craig Coleman as Non-Executive Director 22 Apr 21, 2016: Universal Biosensors Reports Q1 2016 Results 22 Apr 01, 2016: Universal Biosensors-Update 22 Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 23 Feb 19, 2016: Universal Biosensors Announces Retirement of CEO Paul Wright 23 Oct 15, 2015: Development Update: UBI PT-INR Testing System for decentralised and home use 24 Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015 24 May 13, 2015: Siemens Healthcare Diagnostics launches Xprecia Stride Coagulation Analyzer 25 Appendix 26 Methodology 26 About GlobalData 28 Contact Us 28 Disclaimer 28 List of Figures Universal Biosensors Inc Pipeline Products by Equipment Type 5 Universal Biosensors Inc Pipeline Products by Development Stage 9 List of Tables Universal Biosensors Inc Pipeline Products and Ongoing Clinical Trials Overview 4 Universal Biosensors Inc Pipeline Products by Equipment Type 5 Universal Biosensors Inc Pipeline Products by Indication 6 Universal Biosensors Inc, Key Facts 7 Universal Biosensors Inc, Major Products and Services 8 Universal Biosensors Inc Number of Pipeline Products by Development Stage 9 Universal Biosensors Inc Pipeline Products Summary by Development Stage 10 C-Reactive Protein Test-Product Status 11 C-Reactive Protein Test-Product Description 11 Diagnostic Assay-Coagulation-Product Status 12 Diagnostic Assay-Coagulation-Product Description 12 DNA/RNA Blood Glucose Test-Product Status 13 DNA/RNA Blood Glucose Test-Product Description 13 Handheld POC Coagulation Testing System-Ambulatory Care-Product Status 14 Handheld POC Coagulation Testing System-Ambulatory Care-Product Description 14 Immunoassay Test-D-Dimer-Product Status 15 Immunoassay Test-D-Dimer-Product Description 15 PT-INR Testing System-Decentralised And Home Use-Product Status 16 PT-INR Testing System-Decentralised And Home Use-Product Description 16 Universal Biosensors Inc, Key Employees 18 Universal Biosensors Inc, Key Employee Biographies 19 Universal Biosensors Inc, Subsidiaries 20 Glossary 27 Single User License: Site License: Corporate User License: Universal Biosensors Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara" |